JP Stock MarketDetailed Quotes

5741 UACJ

Watchlist
  • 5070
  • 00.00%
20min DelayMarket to Open Mar 11 15:30 JST
245.02BMarket Cap17.64P/E (Static)

UACJ Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

UACJ Q3 2025 Earnings Date

Currency：JPYFeb 12, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
246.71B
251.26B
+4.55B
Beat Est.
+9.49%
+11.51%
+1.84%
EPS
109.63
171.15
+61.52
Beat Est.
+135.51%
+267.67%
+56.12%
Analyst Rating
Buy

Mar 6, 2025

UACJ Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 6, 20252026/Q1-- / 259.846B--
May 13, 20252025/Q4-- / 255.639B--
Feb 12, 20252025/Q3251.260B / 246.710B--
Nov 7, 20242025/Q2239.533B / 250.414B--
Aug 6, 20242025/Q1247.568B / 242.891B--
DatePeriodRevenue/EstimateEarnings Call
Aug 6, 20252026/Q1-- / 259.846B--
May 13, 20252025/Q4-- / 255.639B--
Feb 12, 20252025/Q3251.260B / 246.710B--
Nov 7, 20242025/Q2239.533B / 250.414B--
Aug 6, 20242025/Q1247.568B / 242.891B--

Unlock Free Earnings Estimates

UACJ Earnings Reports

  • UACJ: Notice regarding revisions to dividend forecasts (dividend increases)

    Feb 27 02:00 ET

  • UACJ: 2024 3rd quarter Earnings Conference materials

    Feb 12 01:30 ET

  • UACJ: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2025 [IFRS] (consolidated)

    Feb 12 01:30 ET

  • UACJ: Confirmatory letter.

    Nov 11, 2024 21:55 ET

    • Read more

    Top JP Stock Gainers
    Symbol Price % Chg
    JX Advanced Metals Corporation
    5016
    820 0.00%
    Medix Inc.
    331A
    800 0.00%
    TalentX Inc.
    330A
    750 0.00%
    Tential
    325A
    2710 0.00%
    Booking Resort
    324A
    1548 0.00%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Mar 6, 2025

    Buy

    • Strong Buy

      50.00%

    • Buy

      33.33%

    • Hold

      16.67%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data